Skip to main content
TipRanks
Go Ultimate75% OFF

Nanjing Sinolife United Co., Ltd. Class H (3332) AI Stock Analysis

0 Followers
HK:3332

Nanjing Sinolife United Co., Ltd. Class H

(HKEX:3332)

Select Model
Rating:69Neutral
Price Target:HKD 0.17â–²(16.78% Upside)
Action:reiterated
Date:09/24/26

The score is driven primarily by mid-range financial performance: strong revenue scale-up and high gross margin are offset by sharp post-2023 margin compression and uneven cash flow consistency. Technical signals are moderately positive (price above shorter-term averages with positive MACD), while valuation is supportive with a low P/E.

Positive Factors
Revenue GrowthRevenue expansion across 2020–2025 indicates sustained business growth rather than reliance on a single reporting period. Continued top-line progress can broaden operating scale, support reinvestment, and provide a durable foundation for rebuilding profitability over the next several quarters.
Negative Factors
Profitability CompressionThe sharp decline in net margin since 2023 shows that revenue growth is currently converting into substantially less bottom-line profit. Persistent operating-margin pressure could limit internal funding, weaken returns on capital, and make future earnings more sensitive to cost control and spending decisions.

Nanjing Sinolife United Co., Ltd. Class H (3332) vs. iShares MSCI Hong Kong ETF (EWH)

-80%-60%-40%-20%0%20%40%HK:3332-58.61%EWH+9.24%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
HKD 131.54M
Dividend Yield
―
Average Volume (3M)
148.63K
Price to Earnings (P/E)
6.1
Beta (1Y)
-0.19
Revenue Growth
21.23%
EPS Growth
24.06%
Country
Hong Kong
Employees
533
Sector
Consumer Defensive
Sector Strength
62
Industry
Medical - Pharmaceuticals

Nanjing Sinolife United Co., Ltd. Class H Business Overview & Revenue Model

Company Description

Nanjing Sinolife United Company Limited functions as an investment holding entity primarily involved in the manufacturing, processing, and global distribution of nutritional supplements. Its operations span the People's Republic of China, Australia,...

Nanjing Sinolife United Co., Ltd. Class H Financial Statement Overview

Summary

Solid revenue growth over 2020–2025 and strong gross margin (~73% in 2025) support fundamentals, but profitability has deteriorated meaningfully since the 2023 peak (net margin down to ~3.2% in 2025) and cash flow has been volatile despite a strong 2025 rebound.

Income Statement

68Positive

Balance Sheet

70Positive

Cash Flow

62Positive
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue827.44M772.93M747.90M563.96M274.85M252.32M
Gross Profit626.68M566.18M538.27M379.66M160.00M138.80M
EBITDA36.53M34.87M51.86M75.08M4.88M-13.49M
Net Income19.47M24.66M34.56M52.60M-14.25M-31.71M
Balance Sheet
Total Assets695.27M603.72M505.56M505.42M436.99M390.11M
Cash, Cash Equivalents and Short-Term Investments309.78M240.36M104.53M122.79M78.19M76.23M
Total Debt191.24M107.24M33.90M35.16M35.75M8.87M
Total Liabilities278.30M186.58M111.46M127.35M113.19M59.87M
Stockholders Equity416.97M417.14M394.10M378.07M323.80M330.24M
Cash Flow
Free Cash Flow51.84M64.92M-6.65M44.76M4.05M-9.68M
Operating Cash Flow56.45M68.63M957.00K47.11M7.92M421.00K
Investing Cash Flow-1.89M-725.00K-6.00M449.00K-3.47M1.52M
Financing Cash Flow-50.59M11.84M-4.53M-4.50M-4.08M-4.45M

Nanjing Sinolife United Co., Ltd. Class H Technical Analysis

Technical Analysis SentimentNegative
Last Price0.15

Price Trends

50DMA0.17Negative
100DMA0.16Negative
200DMA0.24Negative

Market Momentum

MACD-0.01Negative
RSI40.11Neutral
STOCH58.30Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:3332, the sentiment is Negative. The current price of 0.15 is below the 20-day moving average (MA) of 0.16, below the 50-day MA of 0.17, and below the 200-day MA of 0.24, indicating a bearish trend. The MACD of -0.01 indicates Negative momentum. The RSI at 40.11 is Neutral, neither overbought nor oversold. The STOCH value of 58.30 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:3332.

Nanjing Sinolife United Co., Ltd. Class H Peers Comparison

Overall Rating

UnderperformOutperform
Sector (62)

Financial Indicators

HK:3332 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
HK:1044HK:104475OutperformHKD 25.79B8.9410.98%7.21%2.19%10.78%
HK:2145HK:214571OutperformHKD 9.32B11.5525.77%6.00%23.19%-22.44%
HK:3828HK:382870OutperformHKD 473.75M5.576.06%10.00%2.24%-39.98%
HK:3332HK:333269NeutralHKD 241.40M6.144.67%―21.23%24.06%
Sector *62Neutral$20.33B14.63-3.31%3.23%1.93%-12.26%
HK:0157HK:015745NeutralHKD 860.90M-14.98-12.81%―13.43%7.72%
HK:6993HK:699341NeutralHKD 16.10B-176.52-1.21%6.22%-2.44%81.73%

* Consumer Defensive Sector Average

Performance Comparison

-75%-50%-25%0%25%HK:3332HK:1044HK:3828HK:0157HK:2145HK:6993Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
HK:3332 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
HK:3332Nanjing Sinolife United Co., Ltd. Class H0.15-0.21-58.61%
HK:1044Hengan International Group Co 22.22-3.82-14.65%
HK:3828Ming Fai International Holdings 0.65-0.22-25.46%
HK:0157Natural Beauty Bio-Technology 0.43-0.08-15.69%
HK:2145Shanghai Chicmax Cosmetics Co., Ltd. Class H23.40-57.20-70.97%
HK:6993Blue Moon Group Holdings Ltd.2.900.238.79%

Nanjing Sinolife United Co., Ltd. Class H Corporate Events

Nanjing Sinolife Overhauls Governance and Uses Reserves to Clear Parent Losses

Sep 4, 2026

Shareholders of Nanjing Sinolife United Company Limited approved, by unanimous poll at an extraordinary general meeting on 4 September 2026, significant amendments to the company’s Articles of Association, including the abolition of its board of supe...

Nanjing Sinolife United Delivers Strong Revenue Growth but Lower Profit in First Half 2026

Aug 24, 2026

Nanjing Sinolife United Company Limited, a PRC-incorporated health and nutrition group listed in Hong Kong, reported solid top-line growth for the six months ended 30 June 2026. The business continues to focus on wellness products for consumers, with...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Sep 24, 2026